Opinion: Telehealth abortion with mifepristone continues, with backup plans still in place

The Supreme Court has ruled that mifepristone, a key drug in medication abortion, can still be accessed via telehealth and mail, despite previous restrictions from the 5th Circuit Court of Appeals. This decision comes amid ongoing legal battles initiated by Louisiana, which argues that telehealth prescriptions violate its strict abortion laws. The case will continue to unfold, but for now, access to this medication remains intact.